Abstract
Adrenal masses are commonly detected with the increasing use of cross-sectional imaging and are reported with a frequency of up to 5 % at general abdominal computed tomography (CT). In addition, they have an increasing incidence with age, as they are detected in about 0.2 % in young people and up to 7 % in the elderly.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Joung WF Jr (2007) The incidentally discovered adrenal mass. N Engl J Med 356:601–610
Lockhart ME, Smith JK, Kenney PJ (2002) Imaging of adrenal masses. Eur J Radiol 41:95–112
Suzuki Y, Sasagawa S, Suzuki H et al (2001) The role of ultrasonography in the detection of adrenal masses: comparison with computed tomography and magnetic resonance imaging. Int Urol Nephrol 32:303–306
Mansmann G, Lau J, Balk E et al (2004) The clinically inapparent adrenal mass: update in diagnosis and management. Endocr Rev 25:309–340
Rush MF, Schneider G, Bhole RM et al (2008) Contrast-enhanced sonography of adrenal masses: differentiation of adenomas and nonadenomatous lesions. AJR 191:1852–1860
Mayo-Smith WW, Boland GW, Noto RB et al (2001) State-of-the-art adrenal imaging. RadioGraphics 21:995–1012
Dunnick NR, Korobkin M (2002) Imaging of adrenal incidentalmomas. AJR Am J Roentgenol 179:559–568
Boland GWL, Blake MA, Hahn PF et al (2008) Incidental adrenal lesions: principles, techniques, and algorithms for imaging characterization. Radiology 249(3):759–775
Song JH, Chaudhry FS, Mayo-Smith WW (2008) The incidental indeterminate adrenal mass on CT: prevalence of adrenal disease in 1,049 consecutive adrenal masses in patients with no known malignancy. AJR Am J Roentgenol 190:1163–1168
Russell C, Goodacre BW, vanSonnenberg E et al (2000) Spontaneous rupture of adrenal myelolipoma: spiral CT appearance. Abdom Imaging 25:431–434
Korobkin M, Giordano TJ, Brodeur FJ et al (1996) Adrenal adenomas: relationship between histologic lipid and CT and MR findings. Radiology 200:743–747
Lee MJ, Hahn PF, Papanicolaou N et al (1991) Benign and malignant adrenal masses: CT distinction with attenuation coefficients, size, and observer analysis. Radiology 179:415–418
Blake MA, Cronin CG, Boland GW (2010) Adrenal imaging. AJR 194:1450–1460
Heinz-Peer G, Memarsadeghi M, Niederle B (2007) Imaging of adrenal masses. Curr Opin Urol 17:32–38
Korobkin M (2000) CT characterization of adrenal masses: the time has come. Radiology 217:629–632
Park BK, Kim CK, Kim B, Lee JH (2007) Comparison of delayed enhanced CT and chemical shift MR for evaluating hyperattenuating incidental adrenal masses. Radiology 243:760–765
Ng L, Libertino JM (2003) Adrenocortical carcinoma: diagnosis, evaluation and treatment. J Urol 169:5–11
Ferrozzi F, Bova D (1995) CT and MR demonstration of fat within an adrenal cortical carcinoma. Abdom Imaging 20:272–274
Heye S, Woestenborghs H, Van Kerkhove F et al (2005) Adrenocortical carcinoma with fat inclusion: case report. Abdom Imaging 30:641–643
Mannelli M, Colagrande S, Valeri A et al (2011) Incidental and metastatic adrenal masses. Semin Oncol 37:649–661
Fujiyoshi F, Nakajo M, Kukukura Y et al (2003) Characterization of adrenal tumors by chemical shift fast-low angle shot MR imaging: comparison of four methods of quantitative evaluation. AJR 180:1649–1657
Outwater EK, Siegelman ES, Radecki PD et al (1995) Distinction between benign and malignant adrenal masses: value of T1-weighted chemical shift MR imaging. AJR 165:579–583
Ramalho M, de Campos RO, Heredia V et al (2011) Characterization of adrenal lesions with 1.5-T MRI: preliminary observations on comparison of three in-phase and out-of-phase gradient-echo techniques. AJR 197:415–423
Israel GM, Korobkin M, Wang C et al (2004) Comparison of unenhanced CT and chemical shift MRI in evaluating lipid-rich adrenal adenomas. AJR 183:215–219
Haider MA, Ghai S, Jhaveri K et al (2004) Chemical shift MR imaging of hyperattenuating (>10 HU) adrenal masses: does it still have a role? Radiology 231:711–716
Blake MA, Kalra MK, Sweeney AT et al (2005) Distinguishing benign from malignant adrenal masses: multi-detector row CT protocol with 10-minute delay. Radiology 238:578–585
Park BK, Kim CK, Kim B et al (2007) Comparison of delayed enhanced CT and chemical shift MR for evaluating hyperattenuating incidental adrenal masses. Radiology 243:760–765
Tsushima Y, Takahashi-Taketomi A, Endo K (2009) Diagnostic utility of diffusion-weighted MR imaging and apparent diffusion coefficient value for the diagnosis of adrenal tumors. J Magn Reson Imaging 29:112–117
Miller FH, Wang Y, McCarthy RJ et al (2010) Utility of diffusion-weighted MRI in characterization of adrenal lesions. AJR 194:W179–W185
Gross MD, Korobkin M, Assaly WB et al (2009) Contemporary imaging of incidentally discovered adrenal masses. Nat Rev Urol 6:363–373
Wong KK, Komissarova M, Avram A et al (2010) Adrenal cortical imaging with I-131 NP-59 SPECT-CT. Clin Nucl Med 35:865–869
Lombardi CP, Raffaelli M, De Crea C et al (2007) Noninvasive adrenal imaging in hyperaldosteronism: is it accurate for correctly identifying patients who should be selected for surgery? Langebecks Arch Surg 392:623–628
Henning J, Lindhe Ö, Bergström M et al (2006) [11C]-Metomidate positron emission tomography of adrenocortical tumours in correlation with histopathological findings. J Clin Endocrinol Metab 91:1410–1414
Boland GWL, Dwamena B, Sangwaiya MJ et al (2011) Characterization of adrenal masses by using FDG PET: a systematic review and meta-analysis of diagnostic test performance. Radiology 269:117–126
Rufini V, Calcagni ML, Baum RP (2006) Imaging of neuroendocrine tumors. Semin Nucl Med 36:228–247
Jacobson AF, Deng H, Lombard J et al (2010) 123I-meta-iodobenzylguanidine scintigraphy for the detection of neuroblastoma and pheochromocytoma: results of a meta-analysis. J Clin Endocrinol Metab 95:2596–2606
Pacak K, Eisenhofer G, Goldstein DS (2004) Functional imaging of endocrine tumors: role of positron emission tomography. Endocr Rev 25:568–580
Rufini V, Treglia G, Castaldi P et al (2011) Comparison of 123I-MIBG SPECT-CT and 18F-DOPA PET-CT in the evaluation of patients with known or suspected recurrent paraganglioma. Nucl Med Commun 32:575–582
Naswa N, Sharma P, Nazar AH, et al (2011) Prospective evaluation of 68Ga-DOTA-NOC PET-CT in phaeochromocytoma and paraganglioma. Preliminary results from a single centre study. Eur Radiol 22:710–719
Timmers HJ, Chen CC, Carrasquillo JA et al (2009) Comparison of 18F-fluoro-L-DOPA, 18F-fluoro-deoxyglucose, and 18F-fluorodopamine PET and 123I-MIBG scintigraphy in the localization of pheochromocytoma and paraganglioma. J Clin Endocrinol Metab 94:4757–4767
Timmers HJ, Kozupa A, Chen CC et al (2007) Superiority of fluorodeoxyglucose positron emission tomography to other functional imaging techniques in the evaluation of metastatic SDHB-associated pheochromocytoma and paraganglioma. J Clin Oncol 25:2262–2269
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer-Verlag Italia
About this chapter
Cite this chapter
Falchini, M., Rufini, V. (2013). Imaging. In: Valeri, A., Bergamini, C., Bellantone, R., Lombardi, C. (eds) Surgery of the Adrenal Gland. Springer, Milano. https://doi.org/10.1007/978-88-470-2586-8_5
Download citation
DOI: https://doi.org/10.1007/978-88-470-2586-8_5
Published:
Publisher Name: Springer, Milano
Print ISBN: 978-88-470-2585-1
Online ISBN: 978-88-470-2586-8
eBook Packages: MedicineMedicine (R0)